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Abstract
Abnormalities inmucus production and qualitative properties such
as mucus hydration are central to the pathophysiology of airway
disease including cystic fibrosis, asthma, and chronic bronchitis.
In vitro air–liquid interface epithelial cell cultures demonstrate
direct relationships between mucociliary transport, periciliary
liquid (PCL) height, andmucus concentration (expressed as percent
solids or partial osmotic pressure). In health, the osmotic modulus/
pressure of the PCL exceeds that of the mucus layer, resulting in
efficient, low-friction movement of mucus. In disease, through
multiple mechanisms, the osmotic pressure of the mucus begins to
exceed basal PCL values, resulting in compression of the cilia and
slowing of mucus transport. The in vivo data in both cystic fibrosis
and chronic bronchitis parallel in vitro data demonstrating that
whenmucus osmotic pressure is increased, mucociliary clearance is
decreased. In chronic bronchitis, there is a direct correlation
between FEV1 and percent solids of mucus, demonstrating a
strong relationship between disease progression and mucus
abnormalities. Animal models, based mechanistically on raised
sodium absorption (and therefore water absorption) from airway
surfaces, mimic the pathophysiology of chronic obstructive
pulmonary disease. Collectively, these data suggest the importance
of mucus concentration in the pathogenesis of airway disease. It is
important to understand the precise mechanisms that result in
mucus hyperconcentration, for example, mucin overproduction
versus abnormal regulation of ion/water transport, which may be
unique to and characteristic of each disease phenotype. The
measurement of mucus concentration may be a simple method to
diagnose chronic bronchitis, monitor its progression, and serve as a
biomarker for development of new therapies.
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Chronic bronchitis is defined
epidemiologically as chronic sputum
production for 3 months for two
consecutive years. Under this definition,
the chronic bronchitic syndrome would
include genetic forms of chronic
bronchitis, for example, cystic fibrosis
and primary ciliary dyskinesia, and
the environmentally driven forms of
chronic bronchitis, typically due to
cigarette smoke. Indeed, to the extent
that asthma often is characterized by
chronic mucus production, it also can be
included as a form of chronic bronchitis;
but it will not be an emphasis of
this review.
As implied by the definition of chronic
bronchitis, abnormalities in mucus
production and abnormal quantitative
and qualitative mucus properties are central
to the pathophysiology of chronic
bronchitis. It is clear that abnormalities in
the mucus production/clearance system
can produce all of the aspects of chronic
bronchitis, including chronic cough,
sputum production, inflammation, and
infection (1, 2). In this review, we cover
the topic of how the mucus clearance
system can be perturbed to produce the
chronic bronchitic phenotype and how
we may better define the progression and
specific chronic bronchitic endotypes in
the future.
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The Airway Mucus Clearance
System in Health and Disease
The normal airway mucus system was
traditionally defined in the context of three
elements: (1) a mobile mucus layer
composed of the secreted mucins
MUC5AC and MUC5B; (2) motile cilia,
beating with a ciliary beat frequency of
approximately 10 Hz; and (3) a watery
periciliary layer in which the cilia beat in a
low-viscosity environment (Figure 1A).
However, this formulation did not
accurately predict why there would be a
single mucus (gel) layer on the airway
surface, and it did not produce quantitative
predictions of mucus clearance rates in
health or disease. The organization of the
mucus ciliary transport apparatus on the
human airway surface has been revisited.
Importantly, a series of biochemical,
immunologic, and biophysical studies
established that there is a “second gel” on
the airway surface (3) (Figure 1B). This gel
occupies the periciliary and cell surface
environment and is composed of the
tethered mucins MUC1, MUC4, MUC16,
and possibly MUC20. Importantly, the
density of the periciliary gel exhibits
gradient-like features, with the more
densely packed gel occurring toward the
epithelial cell surface.
The observation that there are two
gels on the airway surface has immense
implications with respect to the distribution
of water, that is, hydration, on the airway
surface. Both the mucus and the periciliary
gels are “hydrogels” with a density of
mucins that produces a network of
interpenetrating high molecular weight
mucin polymers. In polymer physics terms,
this concentration of mucin molecules
produces a “semidilute” solution. The
water-drawing power of hydrogels is
proportional to their mucin polymer
concentration. Under conditions in which
the polymers are not penetrating or
overlapping, the mucin osmotic water-
drawing power, p, is linearly proportional
to mucin number (n), that is, p = n $ kT.
However, polymers under semidilute,
interpenetrating conditions exhibit a
water-drawing power proportional to the
second to third power of the concentration,
that is, p@ kT/j2.5. Note that j is defined as
the correlation coefficient, which is a
measure of the distance between the nearest
neighboring mucin molecules, that is, a
measure of concentration.
Although mucus viscosity has often
been measured in relation to mucus
transport, we do not for the sake of space
consider it in our analyses of mucus
transport. We would note, however, that
depending on the absence or presence of
interactions between mucin polymers,
mucus concentration is also the dominant
variable controlling mucus viscosity, with
viscosities ranging from the 2.5th to 8.5th
power of concentration (4).
The periciliary gel contributes two
important functions to the airway surface:
(1) It acts as a molecular barrier, preventing
penetration of large particles to the
airway surface; and (2) it acts as a lubricant
layer over which the mucus layer slides
during surface transport. The lubricant
powers of the periciliary liquid (PCL)
heavily depend on its hydration status.
Thus in health, the mucus transport
system works most efficiently when the
osmotic water-drawing power of the PCL,
pPCL, exceeds that of the mucus layer. The
normal airway epithelium possesses
regulatory feedback mechanisms whereby
motile cilia sense the hydration status of
the mucus layer (5). In this scenario, cilia
sense mucus layer osmotic modulus/
concentration properties and, via
mechanical transduction mechanisms,
regulate release of ATP onto the
extracellular surface. Extracellular ATP
concentrations control the relative rates
of fluid absorption (sodium-dependent)
versus fluid secretion (chloride-dependent)
to provide the appropriate amount of salt/
water (hydration) on the airway surface.
Thus, airway epithelia are configured in
health to maintain an airway surface on
which the osmotic modulus/pressure in
the PCL exceeds that in the mucus layer
(pPCL =z500 Pa; pML =z100 Pa), so
that efficient low-friction movement of
the mucus layer over the PCL surface is
maintained.
In disease, there is an imbalance of the
osmotic pressures of the mucus layer
and the PCL, with the osmotic pressure of
the mucus layer rising to values equal to
and exceeding the basal PCL osmotic
pressure value. This situation is achieved in
cystic fibrosis (CF) by virtue of an
imbalance of salt and water transport at the
CF airway surface (6). Abnormal active
epithelial transport of salt and water from
the CF epithelial surface removes water
from the gel with the lowest water-drawing
power, that is, osmotic pressure. Thus,
water is initially extracted from the mucus
layer, increasing its mucin concentration
and osmotic pressure.
In acquired disease, such as chronic
obstructive pulmonary disease (COPD),
the situation is most likely more complex.
Cigarette smoke produces abnormalities
in salt and water transport due to
disruption of cystic fibrosis
transmembrane conductance regulator
(CFTR) transcription and degradation of
extracellular ATP signals by increased
ecto-ATPase expression (7–9).
However, there is also likely a
contribution of increased mucin
secretion, without appropriate salt and
water secretion to the pathogenesis of
hyperconcentrated mucus (10–12).
The functional effect of having a mucus
layer osmotic pressure that exceeds basal
PCL osmotic pressure is osmotic
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Figure 1. Anatomy of the mucociliary apparatus. (A) Traditional view of system as composed of
a mucus layer comprised of secreted mucins that resides over a water periciliary liquid (PCL) layer. (B)
Two-gel (gel on brush) model of mucociliary apparatus. A mucus layer composed of MUC5B and
MUC5AC secreted mucins resides over a periciliary and cell surface environment occupied by a
relatively high density of tethered mucins, including MUC1, MUC4, and MUC16.
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compression of the PCL by the mucus
layer. When it is mild, the osmotic
imbalance will produce compression of the
cilia and slow mucus transport due to
inefficient cilial beat (13). As the disease
progresses, virtually all of the extractable
water will be removed from the PCL and
the mucus layer will adhere to a flattened
cilial surface. It is hypothesized that it is
mucus layer adhesion to the cell surface
that is the initiating factor in both genetic
forms of bronchitis (e.g., CF) and the
acquired forms (e.g., COPD).
The “Cart” versus “Horse”
Problem: The Role of Mucus
Abnormalities Producing
Airway Disease versus
Resulting from Airway Disease
In a recent report, there was a strong
relationship between the degree of mucus
concentration and osmotic pressure, and the
severity of lung disease in COPD (10). The
natural question that arises is whether
the degree of mucus dehydration drives the
severity of lung disease or is a reflection of
the other pathways that produce disease,
with mucus dehydration being secondary.
To address this question, animal models of
selective dehydration of airway surfaces
have been produced. As reviewed elsewhere
in this symposium, approximately a decade
ago Mall and colleagues produced a
transgenic model of epithelial Na1 channel
b subunit (bENaC) overexpression (14).
The model was based on the fact that the
major pathway controlling absorption of
sodium from the airway surface is the
ENaC. Airway epithelial overexpression
of each of the three ENaC genes that
contribute polypeptides to the functional
ENaC, that is, aENaC, bENaC, and
gENaC, revealed that selective
overexpression of bENaC produced
a phenotype of accelerated sodium
absorption. The importance of bENaC in
this phenotype was consistent with data
from others, suggesting that in heterologous
oocyte expression systems selective
expression of aENaC and bENaC
mRNAs produced channels that were
constitutively activated, that is, with an
open probability (Po) of approximately 1
(15). Pharmacologic studies of amiloride
inhibition of bENaC-mediated Na1
currents in wild-type versus bENaC mice
were consistent with the notion of
constitutively activated a/bENaC subunits
in bENaC mice (16).
The unregulated absorption of sodium,
without any molecular perturbation of
Cl– secretory pathways, produced airway
surface liquid volume hyperabsorption in
the bENaC mice. This conclusion
emanated from in vitro studies of airway
surface liquid volume homeostasis by
confocal microscopy and in vivo studies of
freshly harvested mucus concentration,
showing that mucus concentrations were
raised as indexed by a greater percent solids
content (14, 16). A series of studies were
then designed to explore the phenotype of a
murine model in which selective
dehydration of the airway surface by an ion
channel dysregulation mechanism was
achieved. Importantly, airway surface
dehydration appeared to produce the entire
spectrum associated with chronic
bronchitis (17). The features of chronic
bronchitis recapitulated by this model
included the following:
First, there was evidence of widespread
mucus adhesion to, and plugging of,
intrapulmonary airways (18). Direct
measures of extracted mucus revealed an
increase in concentration; bronchoalveolar
lavage studies revealed increased mucin
levels; and electron microscopy studies
indicated the presence of osmotic
compression/flattening of the cilia by an
adherent mucus layer (17).
Second, there was evidence of airway
inflammation (19). This evidence was
derived from bronchoalveolar lavage
studies of bENaC mice that revealed a
persistent increase in neutrophil numbers,
the presence of macrophage activation,
and an increased concentration of
proinflammatory cytokines/chemokines,
including keratinocyte chemoattractant
(KC), LIX, macrophage inflammatory
protein (MIP)-1a, and tumor necrosis
factor (TNF)-a. Histologic evaluation of
bENaC mouse lungs also was consistent
with the presence of neutrophilic
inflammation in airway lumens and
demonstrated the presence of bronchial-
associated lymphoid tissue, an index of
chronic inflammation.
Third, there was evidence of airway
remodeling. Specifically, there was an
increase in the airway epithelial height,
consistent with epithelial proliferation.
Importantly, there was also an increase
in the density of metaplastic goblet cells
with increased stores of both MUC5AC
and MUC5B.
Fourth, there was evidence of infection.
The infection was characterized by a
spectrum of microaerophilic gram-positive
and gram-negative organisms most
prominently seen in the neonatal period
(19). These organisms were also identified
in the oropharynx of neonatal mice.
Thus, it was speculated that the infection
resulted from the aspiration of
oropharyngeal contents that were poorly
cleared in the bENaC mouse.
Finally, a number of novel observations
were made with respect to the pathogenesis
the bronchitis exhibited by the bENaC
mouse model. First, the pulmonary
inflammation appeared to persist in bENaC
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Figure 2. Osmotic pressure of normal versus cystic fibrosis (CF) mucus. Percent solids and osmotic
pressure of induced sputum from normal subjects, spontaneous sputum for subjects with stable CF,
and mucus obtained from CF lungs at the time of transplantation are shown. The dashed line depicts
the basal periciliary liquid (PCL) osmotic pressure value from Button and colleagues (3).
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mice raised in gnotobiotic facilities (19).
This observation suggests that
mucostasis per se, over and above the
effects of bacterial infection of mucus,
can produce the chronic bronchitic
inflammatory phenotype noted in
humans. Second, longitudinal studies
noted the dramatic gene and functional
responses to airway mucus dehydration
provided by airway and alveolar
macrophages (20). Similar to the
neutrophilia in the bENaC mice, the
macrophage activation persisted, and
indeed was perhaps more robust, in
macrophages derived from bENaC mice
raised under gnotobiotic conditions.
Collectively, it appears from these
studies that mucus dehydration and the
predicted osmotically induced mucus stasis
alone can produce the phenotype of
bronchitic lung disease. Of course, disease
in humans is likely not so simple, with
superimposed mechanisms resulting from
environmental conditions that may worsen
the airway mucus dehydration and produce
positive inflammatory feedbacks loops
and accelerated disease progression.
Relevance of Mucus
Dehydration Properties in
Human Disease
As noted previously, cystic fibrosis is
characterized by abnormal ion transport
pathways. In human CF airways, it is likely
that the absence of salt and water secretion,
mediated by defective CFTR chloride/
bicarbonate secretory activity in the
superficial epithelium and in the glands,
contributes to a depletion of airway surface
liquid volume (21, 22). This abnormality is
complemented by the regulatory
abnormality in CF of the epithelial sodium
channel that produces persistent and
inappropriate sodium and liquid absorption
(6). These two problems in combination
produce the severe dehydration of airway
surfaces in CF that leads to CF airway
disease. Note that this airway surface
depletion is heterogeneous in CF, and
reflects the heterogeneity of CF lung
disease. We have speculated that the CF
dehydration phenotype is triggered by
exogenous insults, for example, viral
infection and aspiration, at airway epithelial
surfaces that reveal the CF-limited adaptive
responses to such insults (23).
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Figure 3. Mucus concentration (expressed as percent solids) for normal subjects (NS), cigarette
smokers with normal lung transfer (SM-N), and subjects with chronic bronchitis (CB). (A) Samples
obtained by the filter paper technique. (B) Sputum percent solids and total mucin concentrations of
induced sputum for NS, SM-N, and CB subjects. (C ) Relationship between sputum percent solids
and measured osmotic pressure for subjects with CB. Dashed line depicts basal periciliary liquid
(PCL) osmotic pressure.
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The generation of dehydrated,
hyperconcentrated mucus in patients with
CF has been predicted from in vitro studies
but has recently been confirmed by in vivo
data. Using sputum induced from normal
subjects, sputum obtained from subjects
with CF during periods of clinical stability,
and mucus obtained from CF lungs at the
time of transplantation (i.e., the mucus that
could not be coughed out as sputum), a
relationship was established between mucus
osmotic pressures and previously measured
PCL osmotic pressures (24) (Figure 2).
These data revealed that the normal human
mucus osmotic pressure was indeed
approximately 100 Pa, a value well below
that of the osmotic pressure of the PCL
(500 Pa). The osmotic pressures of normal
subjects were associated with mucus
percent solids concentrations of
approximately 1.5–2%. In CF sputum,
the percent solids contents rose to
approximately 7% and were associated with
osmotic pressures that exceeded basal PCL
values, that is, 600–700 Pa. Importantly, the
mucus that could not be coughed out by
subjects with CF, that is, mucus obtained at
transplantation, showed percent solids in
excess of 10% and mucus osmotic pressures
in the 3,000- to 4,000-Pa range. It is
particularly in this range of mucus
concentration/osmotic pressures that
mucus adhesion is predicted to occur. Thus
it appears likely that mucus dehydration is
a fundamental component of CF lung
disease pathogenesis, and further studies in
earlier and progressive forms of CF lung
disease are warranted.
Similarly, studies have reported the
mucus hydration and mucin concentrations
in normal subjects, smokers without lung
disease, and subjects with cigarette smoke–
induced chronic bronchitis with a spectrum
of FEV1 values and COPD severity (10).
Using direct filter paper sampling to
measure mucus percent solids, it was found
that subjects with cigarette smoke–induced
chronic bronchitis had percent solids
concentration values that were
approximately 2.5-fold higher than those of
normal subjects or smokers with no lung
disease (Figure 3A). Induced sputum
collected from these same subjects revealed
a smaller but significant increase in
percent solids for subjects with CB versus
normal subjects, and the increase in percent
solids was paralleled by an increase in the
total mucin content of CB induced sputum
as compared with normal subjects or
smokers without lung disease (Figure 3B).
Further, the relationship between percent
solids and the osmotic pressure of sputum
from subjects with CB was assessed, and it
was found that there was a proportionate
increase in osmotic pressure as a function
of the increase in percent solids
(Figure 3C). The relationship between
mucus concentration and mucus transport
was tested in vitro, and a direct relationship
between an increase in mucus solids
content and a reduction in mucus transport
rates was observed (10). This relationship
was paralleled by studies in which in vivo
mucus transport, measured by inhaled
radiotracer clearance techniques, was found
to be deceased as a direct function of the
increase in mucus percent solids measured
by the filter paper technique.
The percent solids versus osmotic
pressure relationship for both CF and COPD
sputum samples was compared with the
relationship reported for mucus collected
from sterile human bronchial epithelial
cultures. The relationships between percent
solids and osmotic pressures for both CF and
COPD sputum approximated that of human
bronchial epithelial mucus. This observation
suggests that the inflamed and proteolytic
environment of CF, and to a lesser extent
COPD, airways did not dramatically alter the
osmotic properties of the mucins and large
molecules in diseased sputum (25). Further,
to the extent that there may be small pH
differences between CF and COPD sputum,
these comparisons suggest that pH effects on
osmotic pressure are small compared with
the effects of concentration.
It should be noted that neither direct
transbronchoscopic filter paper sampling
nor sputum techniques for sampling mucus
for study are optimal in patients with
chronic bronchitis that heterogeneously
affects lung surfaces (Figure 4). Direct filter
paper measures avoid oral contamination
but require bronchoscopy and often are
limited to samples from one designated site,
for example, the right main stem bronchus.
The spontaneous sputum technique likely
samples multiple diseased, but not normal,
areas of the central lung. In contrast,
induced sputum, which generates samples
from “normal” areas and diseased areas of
the central lung, may give a better estimate
of average lung mucus properties.
Depending on the experimental question, a
measure of the diseased areas or of average
lung areas, may be advantageous. However,
both sputum techniques suffer from
variable contamination with oral saliva that
contains predominantly MUC5B and is of
low ionic strength. Exhaled breath
condensates have been adapted to sample
small volumes of microaerosols collected
from the expired airstream (26). It is
difficult to directly measure mucin
concentrations in such small samples, but
measurement of the ratio of a mucin
component, sialic acid, to urea may allow
estimates of mucin concentrations in
Figure 4. Heterogeneity of muco-obstructive lung disease with respect to mucin hyperconcentration
and decreased mucus clearance. Green depicts areas of normal mucus concentrations and
clearance; yellow depicts areas of increased mucus concentrations and decreased clearance; and
red depicts areas of very concentrated mucus and mucus adhesion. The heterogeneity of disease
presents broad challenges with respect to mucus sampling, that is, with techniques that harvest
samples from discrete areas of disease and/or region (central vs. peripheral). MC =mucus clearance.
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such samples. However, exhaled breath
condensate samples may sample exclusively
distal airway sites and, again, suffer from
oral contamination.
We have compared induced sputum
with filter paper samples with respect to
measured parameters pertinent to CB. As
noted previously, sputum samples exhibited
a smaller fold percent solids increase in
subjects with CB versus normal subjects as
compared with percent solids filter paper
samples. Predictably, the negative
correlation between percent solids and
in vivo measurements of mucus clearance
was less strong for induced sputum than for
filter paper samples (Figures 5A and 5B).
Variable oral contamination may have
contributed to the decrement in correlation
for induced sputum. As a test of the
contribution of oral contamination to
sputum percent solids, we examined the
relationship between a marker of oral
contamination, squamous cells, and
sputum percent solids. As predicted from
the dilute nature of saliva, a strong negative
correlation between this marker of salivary
contamination and “sputum” percent
solids was observed (Figure 5C).
The observation of large variability
with induced sputum samples is not
unique to percent solids measurements
and has been a common problem in
sputum studies of inflammatory markers
and infection. Regardless of the limitations
of sample collection, it appears that CB
secretions are characterized by increased
percent solids, and this increase may
contribute directly to the decrements in
mucus clearance, and likely the generation
of the mucostasis that characterizes these
subjects.
Conclusions
The data from an animal model and
from the study of two different forms of
chronic bronchitis, that is, the genetic
disease CF and the environmentally induced
COPD, point to the importance of mucus
concentration in the pathogenesis of airway
diseases. Ironically, mucus concentration
has not been a widely explored property of
mucus. This oversight likely reflects the
absence of a biophysical framework to
predict the mechanisms that control mucus
transport and the great importance of
mucus concentration, via the second- to
third power–dependent relationships
between critical biophysical properties
(osmotic pressure), and mucus transport
rates. The recognition that mucus
concentration may be an important,
pathophysiological driver of the bronchitic
phenotype has three implications for
future studies.
First, it will be important to understand
the precise mechanisms that are unique
and characteristic to each disease
phenotype that is characterized by mucus
hyperconcentration. For example, as noted
previously, CF likely reflects early in its
pathogenesis the effects of ion transport
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Figure 5. Correlation of mucus via sample type versus central lung clearance and induced sputum
(IS) contamination. (A) Bronchoscopic filter paper–obtained percent solids versus central clearance
for subjects with chronic bronchitis (CB) (R = –0.387; P = 0.01). (B) Induced sputum values for percent
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defects that produce volume (liquid)
depletion. Later in CF, airway remodeling
with mucus cell hyperplasia and mucin
hypersecretion may worsen mucus
hyperconcentration. Similarly, the causes of
airway mucus hyperconcentration in CB are
likely multifactorial. We would note that
mucin secretion typically is associated with a
proportionate release of ATP and adenosine
that provides a paracrine hydration stimulus
for normal hydration of secreted mucins
(27). The observation that COPD secretions
were associated with decreased ATP and
adenosine levels points to the likely
importance of ecto-ATPases induced by
inflammation as contributors to the
dehydration phenotype in COPD (10).
Second, the recognition that percent
solids (hydration) of mucus is important in
the pathogenesis of CB types of lung disease
suggests that the hydration status of
mucus might be an important biomarker to
identify/characterize patients with CB.
Studies of mucus hydration have thus far
been performed only in patients who were
clinically selected for CB and, hence, it will
be informative to study broader patient
populations in the future. Specifically, it will
be important to study large populations of
subjects with COPD with a spectrum of CB
versus emphysema phenotypes regarding
mucus concentration properties.
Finally, the projected importance of
mucus concentration in CB predicts that
novel therapies should be developed to
normalize the concentration of mucus on
airway surfaces of patients with CB
disease. This goal can be achieved by
increasing the salt and water content on
the airway surface, decreasing mucin
secretion rates, or a combination of both
approaches. n
Author disclosures are available with the text
of this article at www.atsjournals.org.
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